These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24656848)

  • 1. Genetic modification of the relationship between phosphorylated tau and neurodegeneration.
    Hohman TJ; Koran ME; Thornton-Wells TA;
    Alzheimers Dement; 2014 Nov; 10(6):637-645.e1. PubMed ID: 24656848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
    Kim S; Swaminathan S; Shen L; Risacher SL; Nho K; Foroud T; Shaw LM; Trojanowski JQ; Potkin SG; Huentelman MJ; Craig DW; DeChairo BM; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
    Neurology; 2011 Jan; 76(1):69-79. PubMed ID: 21123754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
    Cruchaga C; Kauwe JS; Harari O; Jin SC; Cai Y; Karch CM; Benitez BA; Jeng AT; Skorupa T; Carrell D; Bertelsen S; Bailey M; McKean D; Shulman JM; De Jager PL; Chibnik L; Bennett DA; Arnold SE; Harold D; Sims R; Gerrish A; Williams J; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Peskind ER; Galasko D; Fagan AM; Holtzman DM; Morris JC; ; ; ; Goate AM
    Neuron; 2013 Apr; 78(2):256-68. PubMed ID: 23562540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association and interaction studies of CSF T-tau/Aβ
    Li J; Zhang Q; Chen F; Meng X; Liu W; Chen D; Yan J; Kim S; Wang L; Feng W; Saykin AJ; Liang H; Shen L;
    Neurobiol Aging; 2017 Sep; 57():247.e1-247.e8. PubMed ID: 28641921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size.
    Koran ME; Hohman TJ; Meda SA; Thornton-Wells TA
    J Alzheimers Dis; 2014; 38(1):145-54. PubMed ID: 24077433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.
    Cruchaga C; Kauwe JS; Mayo K; Spiegel N; Bertelsen S; Nowotny P; Shah AR; Abraham R; Hollingworth P; Harold D; Owen MM; Williams J; Lovestone S; Peskind ER; Li G; Leverenz JB; Galasko D; ; Morris JC; Fagan AM; Holtzman DM; Goate AM
    PLoS Genet; 2010 Sep; 6(9):e1001101. PubMed ID: 20862329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease.
    Ott BR; Cohen RA; Gongvatana A; Okonkwo OC; Johanson CE; Stopa EG; Donahue JE; Silverberg GD;
    J Alzheimers Dis; 2010; 20(2):647-57. PubMed ID: 20182051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
    Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
    Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation and neuroimaging measures in Alzheimer disease.
    Biffi A; Anderson CD; Desikan RS; Sabuncu M; Cortellini L; Schmansky N; Salat D; Rosand J;
    Arch Neurol; 2010 Jun; 67(6):677-85. PubMed ID: 20558387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.
    Liu Y; Yu JT; Wang HF; Hao XK; Yang YF; Jiang T; Zhu XC; Cao L; Zhang DQ; Tan L
    PLoS One; 2014; 9(12):e114777. PubMed ID: 25486118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.
    Schuff N; Woerner N; Boreta L; Kornfield T; Shaw LM; Trojanowski JQ; Thompson PM; Jack CR; Weiner MW;
    Brain; 2009 Apr; 132(Pt 4):1067-77. PubMed ID: 19251758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
    Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
    J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts.
    Khondoker M; Newhouse S; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Dobson R; Simmons A; ;
    J Alzheimers Dis; 2015; 45(3):851-64. PubMed ID: 25649652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity.
    Zhu Y; Wu Y; Lv X; Wu J; Shen C; Tang Q; Wang G;
    CNS Neurosci Ther; 2024 Jan; 30(1):e14401. PubMed ID: 37577852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.
    Cong W; Meng X; Li J; Zhang Q; Chen F; Liu W; Wang Y; Cheng S; Yao X; Yan J; Kim S; Saykin AJ; Liang H; Shen L;
    BMC Genomics; 2017 May; 18(1):421. PubMed ID: 28558704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease.
    Wang H; Yang J; Schneider JA; De Jager PL; Bennett DA; Zhang HY
    Neurobiol Aging; 2020 Sep; 93():61-68. PubMed ID: 32450446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
    Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
    Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.